MEP of the week

Lobby organisation

Pfizer Inc.

Business / industry · Health & pharma · HQ: United States · Transparency Register entry

As of 9 September 2026, Pfizer Inc. appears in 45 declared MEP meetings (30 different MEPs), most often with European People's Party.

45
declared meetings
with current MEPs
30
MEPs met
€1.2M/yr
declared lobbying spend
self-reported to the register
1.5
lobbyists
full time equivalent

In their own words

“At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines. Consistent with our responsibility as one of the world's premier innovative…”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 45 declared meetings, by the meeting MEP's political group.

European People's Party1840%
Renew Europe1022%
Socialists & Democrats1022%
European Conservatives & Reformists49%
Patriots for Europe24%
Greens/EFA12%

Meetings by year

Declared meetings per calendar year, 2021–2026. Bar length is relative to its busiest year (14 in 2025).

2021
2
2022
7
2023
6
2024
10
2025
14
2026
6

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Kathleen van Brempt
5 meetings · S&D
Tomislav Sokol
4 meetings · EPP
Andreas Glück
3 meetings · Renew
Stine Bosse
3 meetings · Renew
Jörgen Warborn
2 meetings · EPP

The 15 most recent declared meetings

DateMEPSubject
9 Jun 2026Andreas GlückMDR revision
28 Apr 2026Ingeborg ter LaakBiotech Act
15 Apr 2026Wouter BekeBiotech Act I
26 Mar 2026Vytenis Povilas AndriukaitisBiotech Act
17 Feb 2026Beatrice TimgrenChallenges with Packaging
4 Feb 2026Stine BosseAMR
25 Nov 2025Andi CristeaRecent developments in EU-US trade policy
8 Oct 2025Hildegard BenteleBiotech
1 Jul 2025András Tivadar KuljaCritical medicines act
11 Jun 2025Margarita de la Pisa CarriónBeating Cancer Plan
4 Jun 2025Tomislav SokolHealth policy
4 Jun 2025Romana JerkovićCritical Medicines Act
21 May 2025Andreas GlückCMA
23 Apr 2025Aurelijus VerygaJoint procurement in the Critical Medicines Act – impact on access and EU competitiveness
16 Apr 2025Pascal CanfinOmnibus I

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.